D-peptide inhibitors of TNF (Navigen)

N/A

Report date: 2025/01/26 17:21:23

Base Information

Drug NameD-peptide inhibitors of TNF (Navigen)
Drug Alias NameD-peptide inhibitors of TNF (Navigen)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionTumor necrosis factor inhibitors
TargetsTumor necrosis factor
Therapy Area/IndicationsInflammationInflammatory Bowel DiseasesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNavigen
China Registration ClassN/A

Develop Information

Active CompaniesNavigen
Inactive CompaniesN/A
Active IndicationsInflammationInflammatory Bowel DiseasesArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A